Pieris Pharmaceuticals, Inc. PIRS
13.60 +13.60
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 42.81M | 25.90M | 31.42M | 29.32M | 46.28M | |
| 42.81M | 25.90M | 31.42M | 29.32M | 46.28M | |
| 42.81M | 25.90M | 31.42M | 29.32M | 46.28M | |
| 72.57M | 69.38M | 83.25M | 63.24M | 73.44M | |
| 41.80M | 52.98M | 66.66M | 46.53M | 55.00M | |
| 16.85M | 16.39M | 16.59M | 16.71M | 18.44M | |
| -29.76M | -43.47M | -51.83M | -33.92M | -27.16M | |
| -24.54M | -33.28M | -45.74M | -37.23M | -25.47M | |
| -24.54M | -33.28M | -45.74M | -37.23M | -28.30M | |
| -24.54M | -33.28M | -45.74M | -37.23M | -28.30M | |
| -24.54M | -33.28M | -45.74M | -37.23M | -25.47M | |
| -21.60 | -36.00 | -56.80 | -54.40 | -44.80 | |
| -21.60 | -36.00 | -56.80 | -54.40 | -44.80 | |
| -21.60 | -36.00 | -56.80 | -54.40 | -44.80 | |
| -24.54M | -33.28M | -45.74M | -37.07M | -25.47M | |
| -24.54M | -33.28M | -45.74M | -37.07M | -25.47M | |
| 1.13M | 927.15K | 806.84K | 681.01K | 632.81K | |
| 1.13M | 927.15K | 806.84K | 681.01K | 632.81K |